Adma Biologics | ADMA - Current Liabilities

Stock Price
16.32
Daily Change
0.22 1.37%
Monthly
-3.77%
Yearly
5.15%
Q1 Forecast
15.60

Adma Biologics reported $56.49M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Adma Biologics USD 56.49M 18.45M Sep/2025
Alnylam Pharmaceuticals USD 1.47B 89.13M Dec/2025
BioCryst Pharmaceuticals USD 190.24M 13.08M Sep/2025
Minerva Neurosciences USD 2.67M 143K Sep/2025
Novavax USD 429.87M 40.73M Sep/2025
Omeros USD 85.5M 2.28M Jun/2025
Takeda JPY 2.61T 470.53B Dec/2025